Hostname: page-component-848d4c4894-p2v8j Total loading time: 0 Render date: 2024-05-01T07:37:45.014Z Has data issue: false hasContentIssue false

Orofacial dyskinesia: caused by antidepressants?

Published online by Cambridge University Press:  18 September 2015

A.R. Van Gool*
Affiliation:
Diaconessenhuis Refaja, Afd. psychiatrie
R.C. Van Der Mast
Affiliation:
Diaconessenhuis Refaja, Afd. psychiatrie
P. Moleman
Affiliation:
Diaconessenhuis Refaja, Afd. psychiatrie
*
Diaconessenhuis Refaja, Van der Steenhovenplein 1, 3317 NM Dordrecht

Summary

A case report is presented of a 72 year old woman, who has been treated for a depression with amitriptyline. During the treatment an orofacial dyskinesia develloped. Data in the literature concerning a possible link between the manifestation of orofacial dyskinesia and treatment with antidepressants were mainly found to be case reports. A closer study of the total in all of 25 case reports reveals that the antidepressant is often at most one of more possible determinants of the movement disorder. Particularly, it was frequently noted that patients were treated with other drugs or that the use of other drugs was not specified. A controverse exists in the literature whether or not a so called spontaneous orofacial dyskinesia is found in high frequency in elderly people. For clinical practice the advice is given that, in case an orofacial dyskinesia arises during antidepressant treatment, attention should be paid to other provoking factors in the first place.

Type
Research Article
Copyright
Copyright © Scandinavian College of Neuropsychopharmacology 1991

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Literatuur

1.Yassa, R, Camille, Y, Belzile, L. Tardive dyskinesia in the course of antidepressant therapy: a prevalence study and a review of the literature. J Clin Psychopharmacol 1987;7:243–6.CrossRefGoogle Scholar
2.Tarsy, D. Movement disorders with neuroleptic drug treatment. In: Lake, RC, ed. Clinical Psychopharmacology I. Psychiatr Clin North Am 1984;7:453–71.CrossRefGoogle ScholarPubMed
3.Baldessarini, RJ. Chemotherapy in psychiatry. New York: Harvard Univ. Press 1985:77.Google Scholar
4.Gangat, AE, Luiz, HA, Kajee, AHS, Ibrahim, NI, Simpson, MA. Tricyclic-induced tardive dyskinesia. S afr med J 1987;71:729.Google ScholarPubMed
5.Sedivec, V, Valenova, Z, Paceltova, L. Persistent extrapyramidal oral dyskinesias following treatment with thymoleptics. Act Nerv sup (Praag) 1970;12:67–8.Google ScholarPubMed
6.Roberts, PW. The use of propranonol in treating tardive dyskinesia. Can med Ass J 1980; 123:1106–7.Google Scholar
7.Fann, WE, Sullivan, JL, Richman, BW. Dyskinesias associated with tricyclic antidepressants. Br J Psychiat 1976;128:490–3.CrossRefGoogle ScholarPubMed
8.Deckret, JJ, Maany, I, Ramsey, TA, Mendels, J. A case of oral dyskinesia associated with imipramine treatment. Am J Psychiat 1977;134:1297–8.Google Scholar
9.Woogen, S, Graham, J, Angrist, B. A tardive dyskinesia-like syndrome after amitriptyline treatment. J Clin Psychopharmacol 1981; 1:34–6.Google ScholarPubMed
10.Stancer, HC. Tardive dyskinesia not associated with neuroleptics. Am J Psychiat 1979; 136:727.Google Scholar
11.Gibson, AC. Nomifensine and dyskinesia. Br J Psychiat 1981; 139:439.CrossRefGoogle Scholar
12.Koritar, E. Nomifensine-induced dyskinesia. Can Med Ass J 1985; 133:207.Google ScholarPubMed
13.Barklage, NE, Jefferson, JW. Alternative uses of lithium in psychiatry. Psychosomatics 1987;28:239–56.CrossRefGoogle ScholarPubMed
14.Dinan, TG, Kohen, D. Tardive dyskinesia in bipolar disorder: relationship to lithium therapy. Br J Psychiat 1989;155:55–7.CrossRefGoogle ScholarPubMed
15.Beltman, BD. Tardive dyskinesia reiduced by lithium carbonate. Am J Psychiat 1978; 135:1229.Google Scholar
16.Demuth, GW, Brelow, RE, Drescher, J. The elicitation of a movement disorder by trazodone: a case report. J Clin Psychiatry 1985;46:535–6.Google Scholar
17.Lappiere, YD, Anderson, K. Dyskinesia associated with amoxapine antidepressant therapy: a case report. Am J Psychiat 1983; 140:493–4.Google Scholar
18.Lesser, I. Case report of withdrawal dyskinesia associated with amoxapine. Am J Psychiatr 1983;140:1358–9.Google ScholarPubMed
19.Tao, GK, Harada, DT, Kootsikas, ME, Gordon, MN, Brinkman, JH. Amoxapine-induced tardive dyskinesia. Drug Intell clin Pharm 1985;19:548–9.Google ScholarPubMed
20.Thornton, JE, Stahl, SM. Case report of tardive dyskinesia and parkinsonism associated with amoxapine therapy. Am J Psychiat 1985;141:704–5.Google Scholar
21.Weller, RA, McKnelly, WV. Case report of withdrawal dyskinesia associated with amoxapine. Am J Psychiat 1983;140:1515–6.Google ScholarPubMed
22.Cohen, BM, Harris, PQ, Altesman, RI. Amoxapine neuroleptic as well as antidepressant? Am J Psychiat 1982; 139:1165–7.Google ScholarPubMed
23.Koller, WC, Musa, MN. Amitriptyline-induced abnormal movements. Neurology 1985;35:1086.CrossRefGoogle ScholarPubMed
24.Koller, WC. Idiopathic Oral-facial dyskinesia. In: Jankovic, J, Tolosa, E, ed. Advances in Neurology, Vol. 49. Facial Dyskinesias. New York: Raven Press, 1988; 177–83.Google Scholar
25.D'Alessandro, R, Benassi, G, Cristina, E, Gallassi, R, Manzaroli, D. The prevalence of lingual-facial-buccal dyskinesias in the elderly. Neurology, 1986;36:1350–1.CrossRefGoogle ScholarPubMed
26.Koller, WC. Edentulous orodyskinesia. Ann Neurol. 1983:13;97–9.CrossRefGoogle ScholarPubMed
27.Cunningham Owens, DG, Johnstone, EC, Frith, CD. Spontaneous involuntary disorders of movement. Arch Gen Psychiat 1982; 39:452–61.CrossRefGoogle Scholar
28.Delwaide, PJ, Desseilles, M. Spontaneous buccolinguofacial dyskinesia in the elderly. Acta Neurol Scand 1977;56:256–62.CrossRefGoogle ScholarPubMed
29.Klaans, HL, Barr, A. Prevalence of spontaneous lingual-facial-buccal dyskinesias in the elderly. Neurology 1982;32:558–9.CrossRefGoogle Scholar